Clinical Trials · NCT01028924

Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers

CompletedPhase 1Teduglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Nycomed
Enrollment
72
Start date
Nov 2009
Locations
1 site, Germany
Primary endpoint
ECG measurement/assessment to determine the effect of a single dose of teduglutide on cardiac repolarisation (QT, QTc interval).
View Teduglutide compound reference